Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Unicycive Therapeutics, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
unicycive.comAI Executive Summary
AI-powered analysis of 8-K filing content
Unicycive Therapeutics appointed Meredith S. Manning as an independent director effective October 1, 2026, bringing 25+ years of biopharmaceutical experience and strengthening board governance and oversight capabilities.
Key Takeaways
Meredith S. Manning appointed as independent director with effective date of October 1, 2026
Manning will serve on Audit, Compensation, and Nominating and Corporate Governance Committees, chairing the latter
2 more takeaways
Filing Overview
What This Means
Unicycive Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.